Tom Lees BitMine Scoops Up 151M in Ethereum During Market Downturn US Economic Growth Rebounds in Q1 2026 Fueled by AI Investment and Consumer Spending Fox Business Trumps Beijing Visit Business Spectacle with Musk and Huang Signals Potential Trade Shifts Gold Stabilizes After CPIDriven Volatility Expansion NetScout Systems NTCT Blows Past Q1 2026 Forecasts EPS Hits 052 Superior SGC Extends Rally with 104 Gain 20260521 Nvidia Faces High Stakes as Q1 FY2027 Earnings Approach Amid SkyHigh Expectations IRIDEX Corporation IRIX Delivers Q1 2026 Beat EPS 003 vs 007 Expected Teslas Musk Cites China as Top Rival in Humanoid Robot Race Amid Beijings Workforce Training Push Plus500 Revenue Climbs 11 Reaffirms FullYear Expectations Dekiln Partners with Johnson Tiles for KilnFree Recycled Tile Pilot Novartis Upgrades FullYear Sales and Profit Outlook HoneywellBacked Quantinuum IPO Could Test Recent Quantum Computing Stock Rally AI Terminology Guide Navigating the Language of the Artificial Intelligence Boom SEED Q4 2011 Earnings EPS Surges 117 Above Estimates Strong Operational Execution LFST Q1 2026 Earnings Significant EPS Beat Fails to Lift Shares ALTI Q1 2026 Earnings Earnings Beat Despite Negative Market Reaction HMY Q2 2016 Earnings Earnings Miss Highlights Operational Headwinds MOS Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Rises on Other Factors Ramaco Resources Inc METC Q1 2026 Earnings EPS Misses Estimates amid Operational Challenges Xencor Inc XNCR Holds Ground Near 1131 Key Levels in Focus Ranger Energy Services Faces Headwinds RNGR Drops 35 Amid Sector Pressure Spire Inc Preferred Stock SRJN Edges Higher Amid Steady Yield Demand NeoGenomics Inc NEO Edges Higher as Diagnostic Sector Shows Renewed Interest Banco De Chile ADS BCH Gains as Session Volume Surges Above Support SL Green Realty Corp SLG Rises 174 as Shares Approach Resistance Zone Retail Chain Closing All Stores After 33 Years Latest Signal of Struggling BrickandMortar Sector RXRX Q1 2026 Earnings EPS Beat Despite Stock Decline China SXT Pharmaceuticals SXTC Slips 3 as Stock Tests Key Support Levels